Resmed (RSMDF) Operating Expenses (2009 - 2026)

Resmed has reported Operating Expenses for 18 years, with the latest figure at $391.2 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 15.0% year-over-year to $391.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (up 13.42% YoY), and the FY2025 full-year result was $1.4 billion, up 2.56% from the prior year.
• Operating Expenses for Q1 2026 stood at $391.2 million, up from $387.1 million in the prior quarter.
• The five-year high for Operating Expenses was $391.2 million in Q1 2026, with the low at $256.9 million in Q1 2022.
• Historically, Operating Expenses has averaged $329.7 million across 5 years, with a median of $334.0 million in 2024.
• Annual changes were most pronounced in 2023 — Operating Expenses rose 28.08% — and 2024, when it fell 10.17%.
• Resmed's Operating Expenses stood at $299.5 million in 2022, then rose by 24.14% to $371.8 million in 2023, then declined by 10.17% to $334.0 million in 2024, then grew by 15.88% to $387.1 million in 2025, then increased by 1.06% to $391.2 million in 2026.
• The last three Operating Expenses figures came in at $391.2 million (Q1 2026), $387.1 million (Q4 2025), and $374.3 million (Q3 2025), per Business Quant data.